Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-02-15
1996-11-19
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514365, 514374, 514422, 514444, 5462831, 548203, 548235, 548562, 549 60, 549283, A61K 3144, C07C31102, C07D40104
Patent
active
055763383
ABSTRACT:
Compounds having the Formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.
REFERENCES:
patent: 5424320 (1995-06-01), Fortin et al.
J. Med. Chem., 35:2600-2609 (1992).
Delorme Daniel
Dube Daniel
Ducharme Yves
Friesen Richard
Hamel Pierre
Davis Zinna Northington
Merck Frosst Canada Inc.
Rose David L.
Yang Mollie M.
LandOfFree
Bis (biaryl) compounds as inhibitors of leukotriene biosynthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis (biaryl) compounds as inhibitors of leukotriene biosynthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis (biaryl) compounds as inhibitors of leukotriene biosynthesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541336